Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MDLN
SellMedline Inc. · Healthcare · United States · $47.5B · Avg Vol: $249M/d
32
StockRankGet insider-trade alerts
Q
56
V
38
M
26
P/E (TTM)
43.2x
ROE
4.9%
D/E
0.7x
Dividend %
—
COMPANY DESCRIPTION
Medline Inc. is a global manufacturer and distributor of medical supplies and solutions, serving the entire continuum of care from hospitals and clinics to nursing homes. The company's competitive advantage lies in its extensive product portfolio and vertically integrated supply chain, making it a crucial infrastructure provider to the healthcare industry.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 28.4B | — | 29.9B | 31.2B | 33.7B | 8.8% |
| EPS | -0.01 | 0.13 | 0.66 | -0.01 | 412.8% | 0.80 | 1.52 | 1.57 | 33.8% |
| Shares | — | 799.8M | 812.0M | 812.0M | +1.5% | 877.4M | — | — | — |
| Debt | — | — | — | 12.6B | — | 12.6B | — | — | — |
| Equity | — | 55.0M | 16.5B | 10.7B | 1297.2% | — | — | — | — |
| Op CF | — | — | — | 1.7B | — | 2.0B | — | — | — |
| Inv CF | — | — | — | -474.0M | — | — | — | — | — |
| Fin CF | — | — | — | 399.0M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-9.3%
SMA 50SMA 200
Close
$35.28
RSI (14)
57.4
SCORE BREAKDOWN
Quality
56
ROIC
5.7%59.7
ROE
4.9%56.9
GP/Assets
19.5%45.3
Op. Margin
0.8%46.2
FCF/Assets
3.4%61.1
Piotroski
498.1
Int. Cover
2.5x45.5
D/E Ratio
0.66x23.9
Current Ratio
4.33x67.1
Value
38
P/E (TTM)
43.2x23.3
EV/EBITDA
19.0x34.8
P/FCF
36.6x37.2
P/B
2.6x50.2
P/S
1.6x74.4
Div Yield
—N/A
Momentum
26
52W High %
—N/A
RS 6M
-38%22.6
SMA 50/200
—N/A
EPS Rev 4W
-5.5%14.1
EPS Rev 12W
-5.4%18.4
EPS Improve
+97%73.3
Q Growth
-82%3.1
FUNDAMENTALS
Market Cap
$47.5B
P/E (Forward)
22.0x
Gross Margin
25.1%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MDLN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MDLN | Medline Inc.(you) | $47.5B | 32 | Sell |
| COO | The Cooper Companies, Inc. | $13.9B | 43 | Hold |
| IUI1.DE | Intuitive Surgical, Inc. | $133.0B | 54 | Hold |
| BDX.MX | Becton, Dickinson and Company | $42.9B | 73 | Buy |
| MMED | MiniMed Group, Inc. | $5.7B | 37 | Hold |
| RGEN | Repligen Corporation | $9.9B | 52 | Hold |
| WST | West Pharmaceutical Services, Inc. | $23.7B | 73 | Buy |
| WRBY | Warby Parker Inc. | $3.1B | 33 | Sell |
| RMD | ResMed Inc. | $34.7B | 89 | Strong Buy |
| PLSE | Pulse Biosciences, Inc. | $3.4B | 19 | Strong Sell |
Peer medians: ROE -25.0% · P/E 30.3x · Gross margin 58.8%